business
Bath & Body Works Stock Rises Following Upgrade; Klarna Shares Decline on Guidance
18 Ağustos 2026Bloomberg
- In the latest Stock Movers episode, Klarna's shares fell sharply in premarket trading due to disappointing revenue guidance, despite a profit beat for the second consecutive quarter. Meanwhile, Amylyx Pharmaceuticals saw its stock soar by 54% after positive results from a late-stage trial of its experimental drug.
- Bath & Body Works experienced a surge in stock price following a favorable upgrade from Citi, which raised its recommendation to buy ahead of the company's upcoming earnings release.
- This episode of Stock Movers provides insights into the current market dynamics, showcasing how companies are navigating challenges and opportunities. The differing performances of Klarna, Amylyx Pharmaceuticals, and Bath & Body Works illustrate the diverse factors influencing stock prices, from earnings reports to…
- The contrasting movements of these stocks highlight the volatility in the market, especially in the tech and pharmaceutical sectors. Klarna's decline underscores the impact of external factors like foreign exchange rates on company performance, while Amylyx's success reflects the potential rewards of innovation in h…
NewsAI özeti
This summary is for informational purposes only and does not constitute financial advice. Please consult with a financial advisor before making investment decisions.
Orijinal Kaynak
Tam teknik rapor ve canlı veriler için yayıncının web sitesini ziyaret edin.
Kaynağı Görüntüleİlgili Haberler
Tümünü Gör
NewsAI Mobil Uygulamaları
Her yerde okuyun. iOS ve Android için ödüllü uygulamalarımızı indirin.